Dilated Cardiomyopathy
📧 Sign up to get email alerts when something new happens for Dilated Cardiomyopathy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-11-01Clinical Trial Update: Transcoronary Infusion of Cardiac Progenitor Cells in Pediatric Dilated Cardiomyopathy [Phase 1]
Phase 1 clinical trial assessing transcoronary infusion of cardiac progenitor cells in pediatric dilated cardiomyopathy has completed with r…
-
CLINICAL_TRIALS trial_result · 2021-05-27Clinical Trial Update: Use of Ixmyelocel-T (Formerly Cardiac Repair Cell [CRC] Treatment) in Patients With Heart Failure Due to Dilated Cardiomyopathy (IMPACT-DCM) [Phase 2]
Phase 2 clinical trial investigating Ixmyelocel-T for heart failure due to dilated cardiomyopathy has completed.
-
CLINICAL_TRIALS trial_result · 2021-05-27Clinical Trial Update: Use of Ixmyelocel-T (Formerly Catheter-based Cardiac Repair Cell [CRC]) Treatment in Patients With Heart Failure Due to Dilated Cardiomyopathy [Phase 2]
Phase 2 trial update on Ixmyelocel-T for heart failure due to dilated cardiomyopathy.
-
CLINICAL_TRIALS trial_result · 2021-04-28Clinical Trial Update: A Pilot Trial of Ranolazine to Treat Patients With Dilated Cardiomyopathy [Phase 2]
Phase 2 pilot trial evaluating ranolazine for dilated cardiomyopathy has completed enrollment.
-
CLINICAL_TRIALS trial_result · 2020-12-08Clinical Trial Update: Early Administration of Ivabradine in Children With Heart Failure [Phase 2]
Phase 2 trial update on early administration of ivabradine in children with acute heart failure and dilated cardiomyopathy.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-02-04Clinical Trial Update: Programming Implantable Cardioverter Defibrillators in Patients With Primary Prevention Indication
Completed clinical trial evaluating programming of implantable cardioverter-defibrillators for patients with a primary prevention indication…
-
CLINICAL_TRIALS trial_result · 2018-11-14Clinical Trial Update: Resveratrol: A Potential Anti- Remodeling Agent in Heart Failure, From Bench to Bedside [Phase 3]
A Phase 3 clinical trial evaluating resveratrol as a potential anti-remodeling agent in heart failure due to dilated cardiomyopathy.
-
CLINICAL_TRIALS trial_result · 2018-11-07Clinical Trial Update: A Pilot Project Exploring the Impact of Whole Genome Sequencing in Healthcare [NA]
A completed pilot trial investigated the impact of whole genome sequencing in healthcare, with results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-07-11Clinical Trial Update: Potential Role of Water-soluble Ubiquinol in Complementary Therapy for Pediatric Dilated Cardiomyopathy [NA]
A completed clinical trial investigated water-soluble ubiquinol as a complementary therapy for pediatric dilated cardiomyopathy. The registr…
-
CLINICAL_TRIALS trial_result · 2018-06-11Clinical Trial Update: Influence of Severe Heart Failure to Function and Molecular Biological Parameters of Catabolism in the Human Diaphragm and Peripheral Skeletal Muscle
A completed clinical trial examining how severe heart failure influences functional performance and molecular markers of catabolism in the d…
-
CLINICAL_TRIALS trial_result · 2018-05-02Clinical Trial Update: IMR Assessment in Patients With New Diagnosis of Left Ventricle Dilatation
A completed clinical trial assessing IMR (index of microcirculatory resistance) in patients with newly diagnosed left ventricular dilatation…
-
CLINICAL_TRIALS trial_result · 2018-05-01Clinical Trial Update: Genotype-Phenotype Associations in Pediatric Cardiomyopathy (PCM GENES)
A completed pediatric cardiomyopathy genotype-phenotype study (NCT01873963) sponsored by Wayne State University, examining genotype-phenotyp…
-
CLINICAL_TRIALS trial_result · 2018-04-19Clinical Trial Update: An Integrative-"Omics" Study of Cardiomyopathy Patients for Diagnosis and Prognosis in China
A clinical trial in China is exploring an integrative 'omics' approach to diagnose and prognosticate various forms of cardiomyopathy, includ…
-
CLINICAL_TRIALS trial_result · 2018-03-23Clinical Trial Update: A Single Ascending Dose Study Assessing the Safety, Tolerability, PK and PD of MYK-491 [Phase 1]
This Phase 1 single ascending dose study evaluated the safety, tolerability, pharmacokinetics and pharmacodynamics of MYK-491 in Dilated Car…
-
CLINICAL_TRIALS trial_result · 2018-03-08Clinical Trial Update: Continues Positive Airway Pressure Treatment for Patients With Dilated Cardiomyopathy and Obstructive Sleep Apnea [Phase 3]
An ongoing Phase 3 trial continues to evaluate positive airway pressure therapy for patients with dilated cardiomyopathy and obstructive sle…
-
CLINICAL_TRIALS trial_result · 2018-01-23Clinical Trial Update: Repetitive Intramyocardial CD34+ Cell Therapy in Dilated Cardiomyopathy (REMEDIUM) [Phase 2, Phase 3]
A study update on repetitive intramyocardial CD34+ cell therapy for dilated cardiomyopathy and heart failure (REMEDIUM) spanning phase 2 and…
-
CLINICAL_TRIALS trial_result · 2017-12-15Clinical Trial Update: Harefield Recovery Protocol Study for Patients With Refractory Chronic Heart Failure [Phase 1]
Phase 1 clinical trial update for a Harefield recovery protocol in patients with refractory chronic heart failure; study terminated with res…
-
CLINICAL_TRIALS trial_result · 2017-12-08Clinical Trial Update: Inflammation, Cardiac Sympathetic Innervation, and Arrhythmic Sudden Death
This update notes the completion of a Johns Hopkins trial exploring how inflammation and cardiac sympathetic innervation relate to arrhythmi…
-
CLINICAL_TRIALS trial_result · 2017-11-06Clinical Trial Update: Non-Invasive Evaluation of Myocardial Stiffness by Elastography in Pediatric Cardiology (Elasto-Pédiatrie) [NA]
The Elasto-Pédiatrie study, which evaluates non-invasive elastography for assessing myocardial stiffness in pediatric patients with dilated …
-
CLINICAL_TRIALS trial_result · 2017-08-29Clinical Trial Update: Study of Qiliqiangxin Capsule to Treat Dilated Cardiomyopathy [Phase 4]
Phase 4 clinical trial of Qiliqiangxin Capsule assessing treatment of dilated cardiomyopathy and heart failure has been completed.
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Evaluation of Patients With Known or Suspected Heart Disease
A National Heart, Lung, and Blood Institute–sponsored clinical trial evaluating patients with known or suspected heart disease has completed…
-
CLINICAL_TRIALS trial_result · 2017-05-31Clinical Trial Update: Deactivation of Implantable Cardioverter Defibrillator During Non-thoracic Surgical Procedures
This clinical trial update discusses strategies for deactivating implantable cardioverter-defibrillators (ICDs) during non-thoracic surgical…
-
CLINICAL_TRIALS trial_result · 2017-03-16Clinical Trial Update: Randomized Trial of Interventions to Improve Warfarin Adherence [NA]
A randomized trial evaluated interventions to improve adherence to Warfarin in patients with atrial fibrillation, deep vein thrombosis, and …
-
CLINICAL_TRIALS trial_result · 2017-03-15Clinical Trial Update: A Randomized, Controlled Study to Evaluate Algisyl-LVR™ as a Method of Left Ventricular Augmentation for Heart Failure [Phase 2, Phase 3]
A randomized, controlled study evaluating Algisyl-LVR for left ventricular augmentation in heart failure and dilated cardiomyopathy has comp…
-
CLINICAL_TRIALS trial_result · 2017-03-13Clinical Trial Update: Cell Therapy In Dilated Cardiomyopathy [Phase 3]
This document reports the completion of a Phase 3 clinical trial evaluating a cell therapy for dilated cardiomyopathy.